Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors Treated With Pembrolizumab The prognostic model demonstrated ...
Researchers conducted a systematic review to assess the risk of bias and applicability of prediction models for fear of recurrence in patients with cancer.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果